David Glass, MD, is a leader in skeletal muscle hypertrophy and atrophy research, a member of the National Academy of Sciences in the USA and delivered the 11th HyperMet talk on the 15.5.2025. His contributions include identifying IGF-1-AKT-mTORC1 activity as a major cause of skeletal muscle… [read more]

DFG funding doesn't just mean receiving financial resources. The DFG becomes a contract partner, which, as with all contracts, creates obligations for both parties. Today's presentation by HyperMet science officer Silke Jost will provide an overview of these obligations, the financial framework of… [read more]

Research into the stimulation of muscle growth in ways other than pure training is of interest not only to athletes, but also, for example, to older people who are affected by natural age-related muscle loss, as well as to severely overweight people who have limited mobility.  The market for such a… [read more]

1 March 2025 marked the start of the DFG-funded HyperMet research unit (2 x 4 years), which is headed by Henning Wackerhage (TUM Sports Biology) and Hanna Taipaleenmäki (LMU). On 1 March, Silke Jost also started as HyperMet Science Officer and Moritz Eggelbusch as HyperMet Postdoc in Sports Biology.… [read more]

On the January 17th the DFG-funded HyperMet research unit celebrated the launch of 9 projects and of 8 years of research into the metabolic health effects of skeletal muscle hypertrophy and atrophy. The HyperMet research unit is a DFG-funded consortium of 15 researchers based at the TU Munich, LMU,… [read more]

Our colleagues at TU Braunschweig will offer an outstanding lab course on cellular metabolism. This course will take place from the 6th to the 10th of October 2025. Cellular metabolism plays a crucial role in understanding muscle physiology and adaptation. In this practical course, we will cultivate… [read more]

The official start of the DFG Research Group HyperMet is on 1 March 2025. HyperMet research examines the impact of muscle growth (hypertrophy) and muscle loss (atrophy) on metabolism. Increased muscle mass reduces the risk of obesity, diabetes, osteoporosis, and potentially cancer. We are exploring… [read more]